Predict your next investment

Private Equity
FINANCE | Investment Firms & Funds
novaquest.com

See what CB Insights has to offer

Investments

38

Portfolio Exits

13

Funds

10

Partners & Customers

2

Service Providers

1

About NovaQuest Capital Management

NovaQuest Capital Management (NovaQuest) manages private equity and other investments in the global biopharmaceutical sector, where its principal focus is investing in late-stage clinical assets and commercial phase biopharmaceutical products. NovaQuest contracts with global biopharmaceutical corporations to invest side-by-side in strategic development and commercialization programs.

NovaQuest Capital Management Headquarter Location

4208 Six Forks Road Suite 920

Raleigh, North Carolina, 27609,

United States

919-459-8620

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

NovaQuest Capital Management Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NovaQuest Capital Management Rank

Latest NovaQuest Capital Management News

Phathom Pharmaceuticals announces revenue interest financing agreement for up to $260M

May 4, 2022

The agreement provides for an upfront $100M cash payment and an additional $160M cash payment upon FDA approval of vonoprazan for treatment of EE. Sagard Healthcare Partners, NovaQuest Capital Management and Hercules Capital have committed to providing $260M, including the first $100M payment and commitments for an additional $160M upon EE approval. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

NovaQuest Capital Management Investments

38 Investments

NovaQuest Capital Management has made 38 investments. Their latest investment was in CovenantAH as part of their Secondary Market on November 11, 2021.

CBI Logo

NovaQuest Capital Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/30/2021

Secondary Market

CovenantAH

Yes

2

6/8/2021

Revenue Finance

Dermavant

$160M

Yes

4

5/3/2021

Series A

Aceragen

$35M

Yes

4

2/23/2021

Private Equity

Subscribe to see more

$99M

Subscribe to see more

10

10/19/2020

Private Equity

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/30/2021

6/8/2021

5/3/2021

2/23/2021

10/19/2020

Round

Secondary Market

Revenue Finance

Series A

Private Equity

Private Equity

Company

CovenantAH

Dermavant

Aceragen

Subscribe to see more

Subscribe to see more

Amount

$160M

$35M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

4

4

10

10

NovaQuest Capital Management Portfolio Exits

13 Portfolio Exits

NovaQuest Capital Management has 13 portfolio exits. Their latest portfolio exit was Roivant Sciences on October 01, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/1/2021

Reverse Merger

$99M

4

1/4/2021

Acquired

$99M

18

8/5/2020

Merger

3

8/4/2020

Acq - Fin - II

Subscribe to see more

Subscribe to see more

10

6/15/2018

Acq - Fin - II

Subscribe to see more

Subscribe to see more

10

Date

10/1/2021

1/4/2021

8/5/2020

8/4/2020

6/15/2018

Exit

Reverse Merger

Acquired

Merger

Acq - Fin - II

Acq - Fin - II

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

4

18

3

10

10

NovaQuest Capital Management Acquisitions

6 Acquisitions

NovaQuest Capital Management acquired 6 companies. Their latest acquisition was CoreRX on January 19, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/19/2021

Debt

$99M

$18.5M

Acq - Fin

10

11/2/2018

Subscribe to see more

$99M

Subscribe to see more

10

5/14/2018

Debt

Subscribe to see more

$99M

$99M

Subscribe to see more

10

3/26/2018

Debt

Subscribe to see more

$99M

$99M

Subscribe to see more

10

1/3/2018

Series E+

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

1/19/2021

11/2/2018

5/14/2018

3/26/2018

1/3/2018

Investment Stage

Debt

Debt

Debt

Series E+

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$18.5M

$99M

$99M

$99M

Note

Acq - Fin

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

10

10

10

10

10

NovaQuest Capital Management Fund History

10 Fund Histories

NovaQuest Capital Management has 10 funds, including NovaQuest Private Equity Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/12/2022

NovaQuest Private Equity Fund II

$500M

1

11/5/2019

NovaQuest Private Equity Fund I

Diversified Private Equity

Closed

$275M

6

6/24/2019

NovaQuest Pharma Opportunities Fund V

Diversified Private Equity

Open

$892.75M

5

3/8/2019

NQ PE Project Constellation

$99M

10

6/29/2018

NQ PE Project Kit LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

5/12/2022

11/5/2019

6/24/2019

3/8/2019

6/29/2018

Fund

NovaQuest Private Equity Fund II

NovaQuest Private Equity Fund I

NovaQuest Pharma Opportunities Fund V

NQ PE Project Constellation

NQ PE Project Kit LP

Fund Type

Diversified Private Equity

Diversified Private Equity

Subscribe to see more

Status

Closed

Open

Subscribe to see more

Amount

$500M

$275M

$892.75M

$99M

$99M

Sources

1

6

5

10

10

NovaQuest Capital Management Partners & Customers

2 Partners and customers

NovaQuest Capital Management has 2 strategic partners and customers. NovaQuest Capital Management recently partnered with Grunenthal Group on March 3, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

3/29/2022

Partner

Germany

Grünenthal and NovaQuest enter agreement to advance the resiniferatoxin global Phase III program in osteoarthritis

Aachen , Germany , and Raleigh , North Carolina - Grünenthal and NovaQuest Capital Management announced today that they have entered into an agreement to advance the global clinical Phase III programme of Grünenthal 's asset resiniferatoxin .

4

5/14/2018

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

3/29/2022

5/14/2018

Type

Partner

Partner

Business Partner

Country

Germany

United States

News Snippet

Grünenthal and NovaQuest enter agreement to advance the resiniferatoxin global Phase III program in osteoarthritis

Aachen , Germany , and Raleigh , North Carolina - Grünenthal and NovaQuest Capital Management announced today that they have entered into an agreement to advance the global clinical Phase III programme of Grünenthal 's asset resiniferatoxin .

Subscribe to see more

Subscribe to see more

Sources

4

10

NovaQuest Capital Management Service Providers

1 Service Provider

NovaQuest Capital Management has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Private Equity, and Acq - Fin

Counsel

General Counsel

Service Provider

Associated Rounds

Private Equity, and Acq - Fin

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

NovaQuest Capital Management Team

4 Team Members

NovaQuest Capital Management has 4 team members, including current Chief Financial Officer, Robert Hester.

Name

Work History

Title

Status

Robert Hester

Chief Financial Officer

Current

Ronald Wooten

Managing Partner

Current

John Bradley

Senior Partner

Current

Maulik Mehta

Senior Director

Former

Name

Robert Hester

Ronald Wooten

John Bradley

Maulik Mehta

Work History

Title

Chief Financial Officer

Managing Partner

Senior Partner

Senior Director

Status

Current

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.